|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.
100 项与 Nutrinia Ltd. 相关的临床结果
0 项与 Nutrinia Ltd. 相关的专利(医药)
100 项与 Nutrinia Ltd. 相关的药物交易
100 项与 Nutrinia Ltd. 相关的转化医学